Press release
Patient Engagement Solutions Market to Grow at an Impressive CAGR of ~12.15% by 2032, Driven by Digital Health Adoption and Value-Based Care Models | DelveInsight
Patient Engagement Solutions Market
The increasing prevalence of chronic diseases, aging populations, and higher patient expectations for convenience and transparency are reshaping healthcare delivery. Patient portals, mobile health apps, telemedicine platforms, and remote monitoring tools are enabling real-time interactions, better adherence, and shared decision-making, thereby improving clinical outcomes and reducing healthcare costs.
Technological innovations, including AI-driven chatbots, predictive analytics, wearable-integrated platforms, and omnichannel engagement systems, are further redefining patient care by offering continuous monitoring, personalized reminders, and data-driven care management. Integration with electronic health records (EHRs) and interoperability initiatives are making patient engagement solutions central to coordinated, value-based healthcare ecosystems.
The growing focus on home-based care, telehealth reimbursement, and government initiatives promoting digital health adoption are expanding market opportunities. Additionally, the rising trend of healthcare consumerism and employer-driven wellness programs is supporting the wider deployment of patient engagement tools across various geographies.
Leading players are investing in next-generation platforms that combine engagement, education, and outcome-tracking features, while new entrants are leveraging cloud-based solutions and mobile-first designs to target underserved markets. Strategic partnerships between technology vendors, payers, and providers are further enhancing the scalability and integration of these solutions.
As a result, the patient engagement solutions market is projected to grow at a CAGR of ~12.15% through 2032, reaching significant multi-billion-dollar revenues. Growth will be driven by the shift toward patient-centric care, the expansion of digital health infrastructure, and continuous innovation in connected health technologies.
DelveInsight's Patient Engagement Solutions Market Insights [https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] report delivers a comprehensive analysis of market trends, growth drivers, challenges, regulatory dynamics, and competitive strategies, along with in-depth company profiles of key players shaping the global patient engagement landscape.
Key Takeaways from the Patient Engagement Solutions Market Report
- The patient engagement solutions market, valued at USD 23,880.95 million in 2024, is expected to reach USD 59,499.28 million by 2032, growing at a CAGR of 12.15% from 2025 to 2032.
- As per DelveInsight estimates, North America is anticipated to dominate the global patient engagement solutions market during the forecast period.
- Notable patient engagement solutions companies such as McKesson Corporation, Oracle, Phreesia, OSP Labs, HealthAsyst, Veradigm LLC, athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, and several others are currently operating in the patient engagement solutions market.
- In August 2025, the FDA issued its final guidance on Predetermined Change Control Plans (PCCP) for AI-enabled device software, allowing dynamic updates to digital health and patient engagement solutions without requiring full resubmission.
- In July 2025, the FDA updated its official list of AI-enabled medical devices, adding new categories such as AR/VR and sensor-based digital health technologies, highlighting the growing role of patient engagement platforms within regulated digital health.
- In June 2025, the FDA finalized its Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions guidance, strengthening security requirements for digital health and patient engagement solutions that manage sensitive patient data.
- In January 2025, the FDA released a draft guidance titled "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations", aimed at providing a clear regulatory framework for AI-driven digital health and patient engagement platforms.
To read more about the latest highlights related to the patient engagement solutions market, get a snapshot of the key highlights entailed in the Global Patient Engagement Solutions Market Report [https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Patient Engagement Solutions Overview
Patient engagement solutions refer to technologies, platforms, and strategies designed to involve patients in their own healthcare journey actively. These tools aim to improve communication between patients and healthcare providers, enhance health literacy, and encourage adherence to treatment plans. Solutions often include mobile health apps, patient portals, remote monitoring devices, automated reminders, and telehealth services. By empowering individuals to take a more active role in their care, these systems support better health outcomes and improved patient satisfaction.
The growing demand for personalized care, the rise of chronic diseases, and the increasing adoption of digital health tools are major drivers of the patient engagement solutions market. Healthcare providers are increasingly utilizing these solutions to decrease hospital readmissions, enhance care coordination, and achieve value-based care objectives. As digital transformation continues across the healthcare sector, patient engagement technologies are becoming essential to delivering accessible, efficient, and patient-centered care.
Patient Engagement Solutions Market Insights
In 2024, North America is expected to lead the patient engagement solutions market, driven by the increasing prevalence of chronic diseases such as coronary heart disease and diabetes, largely due to the aging population. The increasing adoption of telehealth, growing demand for patient-centered care, and strong government support for digital health initiatives are fueling market expansion. According to recent CDC and American Heart Association data, millions of U.S. adults are affected by heart disease and diabetes, underscoring the need for effective engagement tools to improve disease management. Telemedicine usage is also on the rise, with 37% of U.S. adults using such services in 2022. Additionally, companies like EnlivenHealth are developing innovative platforms, such as the Patient Engagement Network (PEN), which delivers personalized, timely communication-further driving market growth across the region.
To know more about why North America is leading the market growth in the patient engagement solutions market, get a snapshot of the Patient Engagement Solutions Market Outlook [https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Patient Engagement Solutions Market Dynamics
The global patient engagement solutions market is expanding rapidly, driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and obesity. According to recent data from the British Heart Foundation and the International Diabetes Federation, hundreds of millions of people globally are affected by these diseases, with numbers projected to increase significantly by 2030 and beyond. This growing disease burden, coupled with an aging population, underscores the need for continuous monitoring and patient-centered care. Patient engagement solutions enhance communication between patients and providers, improving outcomes and care coordination-trends evident in countries like the UK and Canada, where virtual care and patient involvement are on the rise. Global initiatives, such as the WHO's Global Initiative on Digital Health (GIDH), and innovations like HSBlox's CureAlign 3.9 platform further support adoption. However, challenges like data privacy concerns and high implementation costs continue to pose barriers to broader market growth.
Get a sneak peek at the patient engagement solutions market dynamics @ https://www.delveinsight.com/report-store/patient-engagement-solution-market [https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Coverage: Global
Study Period: 2022 to 2032
Patient Engagement Solutions Market CAGR: ~12.15%
Key Patient Engagement Solutions Companies: McKesson Corporation, Oracle, Phreesia, OSP Labs, HealthAsyst, Veradigm LLC, athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, and others.
Patient Engagement Solutions Market Segmentation
Market Segmentation By Product Type: Software and Services.
Market Segmentation By Deployment: On-premise and Cloud.
Market Segmentation By End User: Hospitals and Clinics, Home Healthcare, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the patient engagement solutions market are set to emerge as the trendsetters, explore @ Patient Engagement Solutions Companies [https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Table of Contents
1. Electrophysiology Devices Market Report Introduction
2. Electrophysiology Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Electrophysiology Devices Market Key Factors Analysis
6. Electrophysiology Devices Market Porter's Five Forces Analysis
7. Electrophysiology Devices Market Layout
8. Electrophysiology Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=patient-engagement-solutions-market-to-grow-at-an-impressive-cagr-of-1215-by-2032-driven-by-digital-health-adoption-and-valuebased-care-models-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Patient Engagement Solutions Market to Grow at an Impressive CAGR of ~12.15% by 2032, Driven by Digital Health Adoption and Value-Based Care Models | DelveInsight here
News-ID: 4162663 • Views: …
More Releases from ABNewswire
Exosomes Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals …
DelveInsight's, "Exosomes Pipeline Insight, 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Exosomes pipeline landscape. It covers the Exosomes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Exosomes Research. Learn more about…
Gastric Cancer Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA App …
DelveInsight's, "Gastric Cancer Pipeline Insight 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our comprehensive Gastric Cancer Pipeline Report…
COVID-19 Pipeline Insight 2025: Next-Generation Vaccines, Broad-Spectrum Antivir …
The COVID-19 therapeutic pipeline is expanding, focusing on next-gen vaccines, broad-spectrum antivirals, and host-directed immunomodulators to tackle viral evolution and long-term effects. While first-gen vaccines and repurposed antivirals have reduced severe cases and mortality, challenges like waning immunity, new variants, and post-acute sequelae highlight the need for more durable, variant-proof, and disease-modifying treatments.
DelveInsight's "COVID-19 - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/covid-19-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" highlights a diverse set of candidates, including intranasal and pan-variant vaccines…
Nucleic Acid Amplification Testing (NAAT) Market to Grow at a CAGR of ~8.13% by …
The nucleic acid amplification testing (NAAT) market is experiencing robust growth, driven by the rising global burden of infectious diseases, the expansion into oncology diagnostics, and the increasing adoption of point-of-care (POC) molecular testing. NAAT has become the gold standard for detecting viral, bacterial, and genetic markers due to its superior sensitivity, specificity, and rapid turnaround time compared to traditional diagnostic methods.
The market outlook remains highly favorable, with demand supported…
More Releases for Patient
Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Future Growth: Patient Advocacy Solutions Market Sees Promising Growth in 2024 | …
The latest research study released by Worldwide Market Reports on "Patient Advocacy Solutions Market 2024" holds tons of experience in offering comprehensive and accurate analysis of global as well as regional markets. The analysts and researchers authoring the report have provided a deeper competitive analysis of the Patient Advocacy Solutions market along with exhaustive company profiling of leading market players. This research study of the Patient Advocacy Solutions Market involved…
Factors Influencing Global Digital Patient Empowerment Services Market through 2 …
The worldwide "Digital Patient Empowerment Services Market" 2023 Research Report presents a professional and complete analysis of the Global Digital Patient Empowerment Services Market in the current situation. This report includes development plans and policies along with Digital Patient Empowerment Services manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Digital Patient Empowerment Services Market growth, consumption…
Growing Demand For Patient Handling Equipment & Patient Positioning Devices To A …
As per Fact.MR, a market research and competitive intelligence provider, the global patient lateral transfer devices market is anticipated to top US$ 500 Mn by 2031, progressing at a CAGR of 7% over the forecast period of 2021 to 2031.
Lateral transfer is a repositioning aid or equipment that reduces friction and makes it easier and safer to transfer patients laterally.
Patient lateral transfer devices are designed to stay with the…
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, But Imp …
GBI Research, the leading business intelligence provider, has released its latest research, Patient Perspectives Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical needs into the market place. It explores the use of patient reported outcomes in drug development, with a…
